159 related articles for article (PubMed ID: 36849551)
21. A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy.
Lin J; Cai Y; Ma Y; Pan J; Wang Z; Zhang J; Liu Y; Zhao Z
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982415
[TBL] [Abstract][Full Text] [Related]
22. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
23. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
24. Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma.
Shen Y; Cao Y; Zhou L; Wu J; Mao M
Front Mol Biosci; 2022; 9():928006. PubMed ID: 36120545
[No Abstract] [Full Text] [Related]
25. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract][Full Text] [Related]
26. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
[TBL] [Abstract][Full Text] [Related]
27. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
28. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
Xu L; He J; Cai Q; Li M; Pu X; Guo Y
Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
[TBL] [Abstract][Full Text] [Related]
29. Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma.
Zhang Y; Zhuang T; Xin Z; Sun C; Li D; Ma N; Wang X; Wang X
Cells; 2022 Dec; 12(1):. PubMed ID: 36611858
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data.
Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q
Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456
[TBL] [Abstract][Full Text] [Related]
31. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
33. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma.
Gao Y; Jia Z
Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620
[TBL] [Abstract][Full Text] [Related]
34. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
35. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
36. A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.
Yang W; Chen H; Ma L; Dong J; Wei M; Xue X; Li Y; Jin Z; Xu W; Ji Z
Aging (Albany NY); 2022 Dec; 14(24):10107-10124. PubMed ID: 36585925
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implication and immunotherapy response prediction of a costimulatory molecule signature in kidney renal clear cell carcinoma.
Lin G; Yang Y; Feng Q; Zhan F; Sun C; Niu Y; Li G
Immunogenetics; 2022 Jun; 74(3):285-301. PubMed ID: 35119508
[TBL] [Abstract][Full Text] [Related]
38. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract][Full Text] [Related]
40. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]